为切实保障化妆品质量安全，连日来，新疆维吾尔自治区乌苏市市场监管局强化党建引领，积极践 行"实干争先"理念，开展化妆品质量安全专项检查。 下一步，该局将继续加大监管力度，并开展好宣传教育，营造安全放心的化妆品消费环境。（杜志锋、 刘鹏、马婧） 此次专项检查，该局执法人员通过塔通办·扫码检查方式，深入各大商场、超市、化妆品专卖店，以护 肤保湿、防冻防裂类化妆品为重点，查看经营单位进货查验制度执行、产品标签、存储条件、产品保质 期等情况，查看祛斑美白、防脱发类特殊化妆品是否存在非法宣称"药妆、医用面膜、表皮生长因子、 睫毛生长液"等，是否经营变质、超过使用期限的化妆品；是否存在染发类化妆品"一号多用"违法行为 等，杜绝同一文号的染发化妆品标注不同颜色、不同色号、不同适用发质等违法情形，严查不落实化妆 品进货查验制度，严厉打击未经注册备案、标签标识不符合规定、非法添加、自行灌装和使用过期变质 化妆品等违法违规行为。 ...

Core Viewpoint - Beijing Plant Doctor Cosmetics Co., Ltd. is set to go public on the Shenzhen Stock Exchange, showcasing its strong brand power built over 30 years through strategic focus, research, and market expansion [1] Group 1: Company Overview - The Plant Doctor brand was established in 1994 and has focused on the "highland plant skincare" sector, successfully creating iconic product lines such as "Dendrobium," "Purple Ganoderma," and "Cordyceps" [1] - The company has achieved stable revenue growth and continuous profit increase even during challenging industry periods from 2022 to 2024, demonstrating resilience through long-term dedication [1] Group 2: Research and Development - The company has a long-term partnership with the Kunming Institute of Botany, signing a 20-year strategic cooperation agreement in 2014, which has led to significant advancements in research [2] - A key achievement includes the extraction of high-activity Dendrobium oligosaccharides, which has been validated for its effectiveness in promoting collagen production, breaking the monopoly of international brands on high-end skincare ingredients [2] Group 3: Brand Philosophy and Social Responsibility - The brand embodies the philosophy of "respecting nature, valuing science, and giving back to society," collaborating with the UN Development Programme since 2021 on biodiversity and highland plant protection initiatives [3] - Initiatives include the establishment of a biodiversity experience garden and the "Wu Zhengyi Botany Award" to encourage scientific innovation, transforming short-term commercial actions into long-term value investments [3] - The brand's growth strategy integrates ecological protection and social responsibility, enhancing its brand value system and ensuring sustainable development [3]

Group 1 - hince, a niche Korean cosmetics brand, has made significant adjustments to its online presence in China, clearing products from multiple online stores, including its Tmall International flagship store and Douyin overseas flagship store, effective January 1 [1] - The brand previously announced a "suspension of operations" due to strategic adjustments, stating that stores would cease operations on January 1, 2026, but will fulfill existing orders and allow returns within the platform's time limits [1] - A revised announcement on January 9 indicated that the store would undergo a phased adjustment for operational upgrades and service optimization, with ongoing customer service and support [3] Group 2 - hince was established in late 2018 and is owned by Vivawave, emphasizing natural beauty concepts and quickly gaining popularity among the MZ generation in Korea, with sales reaching 21.8 billion KRW in 2022, half of which came from overseas markets [5] - LG Household & Health Care acquired 75% of Vivawave for 42.5 billion KRW in October 2023, aiming to leverage hince's presence in Japan to expand into the mid-to-high-end cosmetics market [5] - LG Household & Health Care has faced performance pressures, with a 6.1% year-on-year decline in sales for the first three quarters of 2025, and has appointed a new CEO to accelerate reforms and enhance product development [6]

Core Viewpoint - The company maintains its profit forecast for 2025-2026 and introduces a net profit forecast of 1.76 billion yuan for 2027, with the current stock price corresponding to a P/E ratio of 26/27 years at 26/21x, maintaining an outperform rating and a target price of 127 HKD, indicating a 47% upside potential [1] Group 1: Company Updates - The company announced a strategic cooperation with LVMH's subsidiary, L Catterton, to expand globally, focusing on acquisitions, strategic investments, capital structure optimization, talent acquisition, and governance [2][3] - The company organized a Hong Kong investor open day, showcasing a robust pipeline of new products and a continued deepening of high-end retail coverage, with initial success in international markets [2] Group 2: Strategic Cooperation - The partnership with L Catterton aims to leverage its global investment network to assist the company in expanding overseas high-end retail channels and to establish a joint equity investment fund focused on the global high-end beauty sector [3] - The collaboration is expected to promote the company's group and global development, opening up long-term growth opportunities [3] Group 3: Management's Shareholding Plan - The company announced that its controlling shareholder and management plan to reduce their holdings by up to 3.51% of the total issued shares within six months through block trades, primarily for investments in the beauty industry and personal financial needs [4] - This clear limit on share reduction is seen as beneficial for stabilizing market expectations and reflects management's confidence in the company's long-term development [4] Group 4: Product Development and Market Performance - The company has a strong pipeline of new products, with the launch of the skincare series "Liu Guang Fu Huo" set for late December and positive market feedback for the new color of the air warehouse lip glaze [5] - Brand building efforts are ongoing, including the release of a documentary series and themed fashion shows, with successful sales of limited edition gift boxes inspired by cultural themes [5] - The company continues to enhance its presence in high-end retail locations, with impressive performance data from its first store in Hong Kong's Harbour City and initial success in international markets [5]

Core Viewpoint - Company maintains profit forecasts for 2025-2026 and introduces a net profit forecast of 1.76 billion yuan for 2027, with current stock price corresponding to 26/27 years P/E ratios of 26/21x, indicating a 47% upside potential [1] Group 1: Company Updates - Company has announced a strategic cooperation with LVMH's subsidiary, Roadway Keten, to expand globally, focusing on acquisitions, strategic investments, capital structure optimization, talent acquisition, and governance [2][3] - The collaboration aims to leverage Roadway Keten's global investment network to enhance the company's overseas high-end retail channels and establish a dedicated equity investment fund for the global high-end beauty sector [3] Group 2: Management and Market Confidence - Company disclosed a plan for major shareholders and management to reduce their holdings by up to 3.51% of the total issued shares within six months, primarily through block trades, to support investments in the beauty industry and personal financial needs [4] - This clear limit on share reduction is expected to stabilize market expectations and reflects management's confidence in the company's long-term development [4] Group 3: Product Development and Market Expansion - Company has a robust pipeline of new products, with the skincare series "Liu Guang Fu Huo" set to launch in late December, and positive market feedback for the new lip gloss color [5] - Brand building efforts are ongoing, including the release of a documentary series and themed fashion shows, alongside successful sales of limited edition products [5] - The company is enhancing its presence in high-end retail locations, with notable performance in Hong Kong and initial success in international markets [5]

Group 1 - The core viewpoint of Haitong International is to maintain an "outperform" rating for Maogeping (01318), with a target price of HKD 108.2, indicating a potential upside of 23.1% based on a 32X PE for 2026. The firm believes that the brand strength and fundamentals remain solid, with the company's core value lying in its strong high-end brand positioning and continuous product innovation [1] Group 2 - Haitong International expects Maogeping to continue strong growth in the second half of 2025, benefiting from robust offline same-store performance driven by sales volume, despite a weakening consumer spending power in the latter half of the year. The expansion of membership and high repurchase rates support sales growth [2] - The company is projected to achieve revenues of RMB 5.101 billion, RMB 6.489 billion, and RMB 8.115 billion for 2025-2027, representing year-on-year growth of 31.3%, 27.2%, and 25.0% respectively. Net profit attributable to the parent company is expected to be RMB 1.201 billion, RMB 1.494 billion, and RMB 1.848 billion for the same period, with growth rates of 36.4%, 24.4%, and 23.7% respectively [2] Group 3 - The company has signed a strategic agreement with investment institution Luwei Kaiteng to inject internationalization and capitalization momentum, focusing on global market expansion, establishing a high-end beauty investment fund, and optimizing corporate governance. This collaboration is expected to significantly enhance the company's penetration in overseas high-end markets and open up avenues for future growth through the investment fund platform [3] Group 4 - The company's controlling shareholders and some directors plan to reduce their holdings by up to 3.51% of the total share capital, equating to a maximum of 1,720 shares, valued at approximately HKD 15.1 billion based on the closing price of HKD 87.95 per share on January 7. The reduction is primarily for personal financial planning, and the company emphasizes that this will not lead to a change in control, as the founding family will maintain around 70% ownership [4]

Group 1 - The core viewpoint of Haitong International is to maintain an "outperform" rating for Maogeping (01318), with a target price of HKD 108.2, indicating a potential upside of 23.1% based on a 32X PE for 2026. The firm believes in the company's strong brand power and fundamentals, highlighting its high-end brand positioning and continuous product innovation as key value drivers [1][2]. Group 2 - It is anticipated that Maogeping will continue its strong growth in the second half of 2025, benefiting from robust offline same-store performance driven by sales volume, despite a weakening consumer spending environment. The expansion of membership and high repurchase rates are expected to support sales growth [2]. - The company is projected to achieve revenues of CNY 5.101 billion, CNY 6.489 billion, and CNY 8.115 billion for 2025-2027, reflecting year-on-year growth rates of 31.3%, 27.2%, and 25.0%, respectively. Net profit attributable to the parent company is expected to be CNY 1.201 billion, CNY 1.494 billion, and CNY 1.848 billion, with growth rates of 36.4%, 24.4%, and 23.7% [2]. Group 3 - The company has signed a strategic agreement with investment institution Luwei Kaiteng to inject internationalization and capitalization momentum, focusing on global market expansion, establishing a high-end beauty investment fund, and optimizing corporate governance. Successful implementation of this cooperation is expected to significantly enhance the company's penetration in overseas high-end markets [3]. Group 4 - The company's controlling shareholders and some directors plan to reduce their holdings by up to 3.51% of the total share capital, equating to a maximum of 1,720 shares, valued at approximately HKD 15.1 billion based on the closing price of HKD 87.95 per share on January 7. The company emphasizes that this reduction will not lead to a change in control, as Maogeping and its relatives will maintain around 70% of the company's equity [4].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining global attention in the health industry for its potential anti-aging, DNA repair, and metabolic regulation benefits, with significant regulatory advancements expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2][19]. Regulatory Environment - The global regulatory landscape for NMN is shifting from strict restrictions to cautious openness, with significant milestones achieved in countries like Japan, Canada, the US, and Australia [17][18]. - In China, NMN has been approved as a new cosmetic ingredient and is on the path to becoming a recognized health food, with the National Market Supervision Administration listing it for health food approval in April 2025 [17][18]. Market Demand - The aging population in China is driving the "silver economy," with projections indicating that the elderly population will grow from 320 million to 390 million between 2025 and 2030, creating a substantial market for anti-aging products [19]. - The younger generation, particularly those born in the 1990s, is increasingly aware of anti-aging needs, further boosting market demand for NMN products [19]. Technological Advancements - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry forward, with full enzyme methods significantly enhancing production efficiency and reducing costs [21][22]. - The transition from chemical synthesis to full enzyme methods is leading to higher purity and environmental sustainability in NMN production [10][12]. Application Areas - NMN is primarily used in health supplements and cosmetics, with the health supplement market accounting for nearly 90% of its applications, including anti-aging and immune support products [24][28]. - Future applications are expected to expand into pet nutrition, medical health, and agricultural technology, opening new growth avenues for the industry [24][28]. Market Size and Growth - The NMN market in China is projected to exceed 3 billion yuan by 2025, driven by increasing regulatory clarity and expanding applications in various sectors [28][32]. - The market has been growing steadily since 2020, with significant penetration into health supplements and cosmetics [28][32]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60% to 70% of market share [35][34]. - Brand private channels are also showing strong performance, capturing about 30% of the market share [35]. Certification and Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. - Achieving this certification could significantly reshape the market landscape for NMN products in China [37]. Future Prospects - The NMN industry is poised for growth, with regulatory breakthroughs expected to enhance market opportunities, particularly in the cosmetics sector [51]. - The potential for NMN in pet nutrition, medical health, and agricultural technology is also being explored, indicating a broadening of its application scope [53][56][58].

Core Viewpoint - The article discusses the financial success and wealth accumulation of the beauty mogul Mao Geping, highlighting the recent share reduction announcement by his company, Mao Geping Cosmetics, and the implications for shareholders and the market [2][3][6]. Company Overview - Mao Geping Cosmetics, known as the "first high-end domestic beauty stock," has a market capitalization of HKD 42.25 billion as of January 8, 2024, with projected revenue exceeding HKD 3.8 billion for the year [3][10]. - The company was founded in July 2000, marking the beginning of the Geping family's wealth journey in the beauty industry [5]. Wealth Accumulation - Mao Geping and his wife, Wang Liqun, have a combined wealth of RMB 12.5 billion, ranking them 2188th on the 2025 Hurun Global Rich List [3][8]. - The family plans to cash out up to HKD 1.41 billion through a share reduction of 17.2 million H shares, representing 3.51% of the total share capital [10]. Shareholding Structure - The Geping family holds a significant portion of the company's shares, with Mao Geping and Wang Liqun owning approximately 29.22% of the total shares, while other family members collectively hold over 50% [11][13]. Financial Performance - Mao Geping Cosmetics has experienced rapid growth, with a compound annual growth rate (CAGR) of 35.04% in revenue and 38.56% in net profit from 2021 to 2024, significantly outpacing industry averages [16]. - Revenue figures from 2021 to 2024 are as follows: RMB 1.577 billion, RMB 1.829 billion, RMB 2.886 billion, and RMB 3.885 billion, with net profit increasing from RMB 331 million to RMB 881 million [16]. - In the first half of 2025, the company reported revenue of RMB 2.588 billion and a net profit of RMB 670 million, both showing over 30% growth [16]. Product Portfolio - The company's flagship brand, "MAOGEPING," contributes over 99% of its revenue, with a diverse product range including makeup, skincare, and fragrance [17]. - Notable products include the "Luxury Caviar Cushion" and "Light Sense Soft Color Powder Cake," each generating over RMB 200 million in retail sales in the first half of 2025 [19]. Cash Flow and Profitability - As of mid-2025, the company had cash reserves of RMB 3.89 billion, with net cash flow from operating activities increasing by 145.7% [19]. - The gross profit margin has remained stable above 83% from 2021 to 2025, outperforming competitors like Proya and Shanghai Jahwa [16]. Future Outlook - The Geping family’s wealth is expected to continue growing with the expansion into new markets and product lines, including fragrances and international markets [20].

Core Viewpoint - The company is currently finalizing its financials and will disclose specific data in its annual report on April 23. The sales data for the first three quarters of 2025 indicates significant impact from the optimization of offline sales channels, which the company is actively adjusting to ensure long-term healthy development of its offline business [1] Group 1 - The company is transitioning its offline sales model from traditional distribution to a value-driven sales approach to create better conditions for long-term growth [1] - The optimization of offline sales channels is showing noticeable effects, although it may take time for sales data to reflect this change [1] - The company believes that as the channel model transforms and the offline market stabilizes, both distributors and sales terminals will improve, leading to healthy growth in the company's offline business [1]